CT News and Research

RSS

FDA probes excessive radiation dose cases

The Associated Press/Wall Street Journal: "Federal health regulators are investigating reports of dangerous radiation levels at two more California hospitals, following earlier unsafe medical scans at a Los Angeles facility. The Food and Drug Administration is probing the use of CT scans at Glendale Adventist Medical Center and Providence St. Joseph Medical Center in Burbank, Calif. The brain scans are used to diagnose strokes.

8 Dec 2009

Excess radiation exposure during CT perfusion imaging: FDA issues interim recommendations

As part of an ongoing investigation into cases of excess radiation during CT perfusion imaging of the brain, the U.S. Food and Drug Administration today provided imaging facilities and practitioners with interim recommendations to help prevent additional problems.

8 Dec 2009

Defibrotide drug effective against hepatic veno-occlusive disease

Defibrotide, a novel drug which modulates the response of blood vessels to injury, was markedly more effective than standard treatment in post-stem cell transplant patients with hepatic veno-occlusive disease, a life threatening toxicity of transplant caused by blockages in tiny blood vessels of the liver, according to a study led by Dana-Farber Cancer Institute scientists.

8 Dec 2009

H1N1 virus produces pulmonary damage similar to earlier flu pandemics

In fatal cases of 2009 H1N1 influenza, the virus can damage cells throughout the respiratory airway, much like the viruses that caused the 1918 and 1957 influenza pandemics, report researchers from the National Institutes of Health (NIH) and the New York City Office of Chief Medical Examiner.

8 Dec 2009

Combination of chemotherapy and midostaurin drug may benefit AML patients with FLT3 mutations

A targeted drug that is active against acute myeloid leukemia (AML) is particularly effective when teamed with chemotherapy in patients whose cancer cells harbor a key genetic mutation, researchers at Dana-Farber Cancer Institute and their colleagues will report at the American Society of Hematology's (ASH) annual meeting on Monday, Dec. 7 (Ernest N. Morial Convention Center, Room 343-345, 5:15 pm CT).

8 Dec 2009

BD Diagnostics receives FDA clearance on Amplified DNA Assays

BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), announced today it has received clearance from the U.S. Food and Drug Administration (FDA) to utilize its BD ProbeTec(TM) Chlamydia trachomatis (CT) Qx and BD ProbeTec(TM) Neisseria gonorrhoeae (GC) Qx Amplified DNA Assays with samples collected during women's routine liquid-based Pap testing for cervical cancer screening.

From BD (Becton, Dickinson and Company) 8 Dec 2009

New PenLink connectivity package installed at Zwanger-Pesiri Radiology

The Medipattern Corporation, a pioneer in the development of medical software solutions that help improve imaging workflow and productivity, and PenRad Technologies, Inc., a leader in the development of mammography information systems (MIS) are pleased to announce the first installation of the new PenLink connectivity package at Zwanger-Pesiri Radiology, Long Island's largest private medical imaging practice.

7 Dec 2009

New three-drug combination may be effective for treating patients with bone cancer

A new three-drug combination has shown in a phase 1/2 clinical trial that it is a "highly effective regimen" in the treatment of patients newly diagnosed with multiple myeloma, a cancer of white blood cells in bone marrow, say researchers from Dana-Farber Cancer Institute.

7 Dec 2009

Bortezomib can improve control of GVHD and immune system recovery

A drug that has become a mainstay of multiple myeloma treatment may outperform alternative therapies in re-establishing the immune system of patients who have received stem cell transplants from unrelated, partially matched donors, according to early clinical trial results to be presented by Dana-Farber Cancer Institute investigators at the American Society of Hematology's (ASH) annual meeting on Sunday, Dec. 6 (Abstract 48, Ernest N. Morial Convention Center, Room 243-245, 5:45 pm CT).

6 Dec 2009

Bayer Diabetes Care announces the winners of 'Express Your Simple Win Creativity Contest'

Bayer Diabetes Care today announced the three grand prize winners of Bayer's "Express Your Simple Win Creativity Contest." Nick Jonas, of the Jonas Brothers, selected the winning video entries submitted by children with diabetes from across the country.

5 Dec 2009

New diagnostic guidelines for inexpensive and accurate detection of lung cancer

A simple, inexpensive computer tool that measures volume changes in the size of suspicious nodules in the lungs picked up by a CT scanner can rule out non-cancerous ones with almost perfect accuracy and enable doctors to diagnose true cancers with fewer, less expensive and less invasive tests.

5 Dec 2009

Joint Commission's Accreditation for Shared Imaging

Shared Imaging, LLC, an independent provider of CT, MRI and PET/CT systems and service programs for hospitals and healthcare providers, is excited to announce it has received The Joint Commission's Accreditation for Ambulatory Health Care, a nationally-recognized, prestigious gold seal of approval for quality and safety in patient care.

4 Dec 2009

PACS injection-record integration capabilities demonstrated at RSNA

Radiology imaging leader MEDRAD, Inc. demonstrated PACS injection-record integration capabilities at the November 2009 Radiology Society of North America in Chicago.

4 Dec 2009

Health leaders to discuss latest breast cancer findings at CTRC-AACR San Antonio Breast Cancer Symposium

Now in its 32nd year, the CTRC-AACR San Antonio Breast Cancer Symposium continues to attract the best in breast cancer science and world leaders from industry and academia with the goal of eradicating breast cancer.

4 Dec 2009

Cancer-free status does not lead to resumption of smoking among former smokers

Assurance of a cancer-free status did not prompt people participating in a long-term computerized tomography (CT) lung-cancer screening program to pick up their cigarettes again, researchers wrote in a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

4 Dec 2009

Caliper Life Sciences releases Living Image 4.0 software for its IVIS in vivo imaging systems

Caliper Life Sciences, Inc., a leading provider of tools and services for drug discovery and life sciences research, today introduced Living Image 4.0 software for IVIS® in vivo imaging systems. Living Image software drives the more than 800 Caliper IVIS systems currently installed in laboratories worldwide.

3 Dec 2009

TGen scientists win $1,000 prize for best scientific paper presented at BIBM09

A team of scientists at the Translational Genomics Research Institute (TGen) won a $1,000 prize for best scientific paper presented at BIBM09, a premier bioinformatics and biomedicine conference.

3 Dec 2009

First computerized crash model to test how crash forces affect the human body

Although states are not required to report fetal deaths in accident data, between 300 and 1,000 unborn babies die in car accidents each year. This accident fatality rate is about four times the rate for victims between infancy and four years old, said Stefan Duma, head of the Virginia Tech --- Wake Forest University School of Biomedical Engineering and Science (SBES).

3 Dec 2009

Dementia patients with certain changes in their brain's white matter more likely to be apathetic

Dementia patients with a certain type of changes in their brain's white matter are more likely to be apathetic than those who do not have these changes, reveals a patient study carried out by the Sahlgrenska Academy and Sahlgrenska University Hospital.

3 Dec 2009

CT imaging after chemotherapy with bevacizumab may help predict overall survival

Preliminary research suggests that criteria based on computed tomography (CT) imaging of changes in tumors from colorectal liver metastases after chemotherapy with the drug bevacizumab may have the potential to predict overall survival, according to a study in the December 2 issue of JAMA.

3 Dec 2009

CT News and Research

FDA probes excessive radiation dose cases

Excess radiation exposure during CT perfusion imaging: FDA issues interim recommendations

Defibrotide drug effective against hepatic veno-occlusive disease

H1N1 virus produces pulmonary damage similar to earlier flu pandemics

Combination of chemotherapy and midostaurin drug may benefit AML patients with FLT3 mutations

BD Diagnostics receives FDA clearance on Amplified DNA Assays

New PenLink connectivity package installed at Zwanger-Pesiri Radiology

New three-drug combination may be effective for treating patients with bone cancer

Bortezomib can improve control of GVHD and immune system recovery

Bayer Diabetes Care announces the winners of 'Express Your Simple Win Creativity Contest'

New diagnostic guidelines for inexpensive and accurate detection of lung cancer

Joint Commission's Accreditation for Shared Imaging

PACS injection-record integration capabilities demonstrated at RSNA

Health leaders to discuss latest breast cancer findings at CTRC-AACR San Antonio Breast Cancer Symposium

Cancer-free status does not lead to resumption of smoking among former smokers

Caliper Life Sciences releases Living Image 4.0 software for its IVIS in vivo imaging systems

TGen scientists win $1,000 prize for best scientific paper presented at BIBM09

First computerized crash model to test how crash forces affect the human body

Dementia patients with certain changes in their brain's white matter more likely to be apathetic

CT imaging after chemotherapy with bevacizumab may help predict overall survival

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News